Connect with us
Advertisement
Advertisement

Health

Milford mum first to receive groundbreaking new MS treatment

Published

on

A MILFORD HAVEN mum has become the first NHS patient in the UK to be treated with a new drug to prevent relapses of multiple sclerosis (MS).

The newly approved medication, ublituximab, is given through an intravenous (IV) infusion and used to help treat relapses of MS.

Compared to other treatments, the drug can be given much faster through an IV infusion, allowing more patients to be treated sooner.

MS, a lifelong condition, happens when a person’s immune system attacks their brain and spinal cord.

The immune system creates cells that attack and kill viruses in the body but for those with MS, the cells attack the nerves instead.

This week, Monday 28th April to Sunday 4th May marks MS Awareness Week.

Fiona Creelie, from Milford Haven, was the first patient to be treated with the new drug at the Jill Rowe Neurology Ambulatory Unit at Morriston Hospital in Swansea.

“I started experiencing pins and needles and sharp shooting pains in my face in September,” the 35-year-old said.

“They initially thought it was trigeminal neuralgia, which is sudden, severe facial pain.

“In November, I started to get the same sensations down my right arm, so I went to A&E and had an MRI scan and lots of other tests and then was referred to Morriston Hospital.”
The mum-of-one only officially received her diagnosis of MS and just two weeks later received her first IV treatment of the new drug.

Fiona added: “I was offered a selection of three drugs, but I picked this one because it fitted in with our family life.

“This treatment will be once every six months for just an hour each time, so it was the best fit for me.

“It’s a bit crazy to have been the first person to receive the treatment but it’s also really exciting.”

With the new treatment able to be given much quicker, it will help to reduce the time patients wait for treatment.

Dr Owen Pearson, consultant neurologist at Morriston Hospital, said: “The drug itself is a new version of an already approved drug, but the advantage is that it’s given faster, through an IV infusion.

“It allows us to treat more patients per day and that allows us to shorten the waiting time for treatment.

“It is a highly effective treatment which helps to stop focal inflammation, which is new lesions appearing on an MRI, or having new relapses of MS.

“The unit was starting to operate above capacity so the introduction of this drug will help with that.

“Clinical trials for the drug were done in other centres in the UK, including Cardiff, and it has recently been approved for use on the NHS.

“Being able to offer it so quickly to our patients in Swansea Bay involves a lot of working together with the pharmacy department.

“We have a dedicated clinical pharmacist within our team which allows us to deliver new treatments like this to our patients.”

Charles-Henry Her, the team’s clinical pharmacist, added: “The consultants are really proactive in finding out about these new drugs and then they provide me with all of the information I need.

“I learn about the new drugs and how they work and make sure our systems are ready for us to introduce them.”

Around 2,200 MS patients are supported in Swansea Bay, with the service seeing patients from Machynlleth, in Powys, right across to Cowbridge, in the Vale of Glamorgan.

Dr Gillian Ingram, consultant neurologist, said: “The fact that the treatment is much shorter will allow more MS patients to come through.

“It is also beneficial for patients to have a choice of treatment, so they can choose the option that’s right for them.

“There are always new developments in treatments for MS and it is really nice to keep Wales at the forefront of that.”

Alexandra Strong, Jill Rowe Neurology Ambulatory Unit manager, said: “It is exciting for both patients and our unit to have another treatment available for MS, and it was exciting for us to be the first to give the treatment in the NHS.

“It is another option for patients to help improve their treatment and health.

“It will allow more flexibility for patients as it will make it much easier to fit in with their lifestyle, while it will also allow us to be more flexible with the treatment we can offer too.”

 

Health

RCN Wales appoints Nicola Williams as Executive Director

Published

on

NICOLA WILLIAMS will take up the role in April, bringing more than three decades of experience in nursing and senior leadership.

The Royal College of Nursing (RCN) has announced the appointment of Nicola Williams as its new Executive Director for Wales.

She joins the organisation from Velindre University NHS Trust, where she currently serves as Executive Director for Nursing, Allied Health Professionals and Health Care Scientists. With 38 years of experience in nursing and more than six years at executive board level, she is widely recognised across NHS Wales for her work in improving patient outcomes.

A highly experienced strategic leader, Williams has worked across a wide range of clinical and organisational settings. She has led major transformation programmes, strengthened national clinical leadership networks and championed innovation and evidence-based improvements in care. Her work has contributed to changes adopted across Wales and has been recognised with national awards.

Speaking about her appointment, Nicola Williams said: “I feel privileged to be appointed as Executive Director of RCN Wales. I’m a proud nurse, passionate about patient safety and improving care standards.

“Delivering the best care is only possible when nursing staff are supported to work in safe, inclusive environments. I will stand alongside members and their patients.

“Nursing staff are the backbone of health and care. I am determined to support our members across Wales, wherever they work, to meet the challenges ahead and shape the future of our profession.

“I look forward to meeting members across Wales and ensuring our work is informed by their experiences and expertise.”

In her new role, Williams will lead the RCN’s work in Wales and provide strategic leadership across key priority areas spanning the UK.

She succeeds Helen Whyley, who has held the position since February 2019 and will move into a new role as Director of Service Innovation at the RCN.

 

Continue Reading

Health

Decision pending on adult mental health referral pathway

Published

on

HYWEL DDA University Health Board will decide next week whether to make changes to the GP referral pathway for routine adult mental health services permanent.

The decision will be taken at a public Board meeting on Thursday (Mar 26).

Board members will consider a proposal to formalise changes already introduced in Ceredigion and, if approved, roll out the revised pathway across Pembrokeshire and Carmarthenshire.

Since March 2025, adults in Ceredigion seeking routine mental health support have been advised by their GP to contact the NHS 111 Wales ‘Press 2’ service, rather than being referred directly to the county’s Community Mental Health Team.

The temporary change was introduced in response to ongoing staffing shortages. Health Board officials say the approach has helped maintain timely access to face-to-face assessments for those who need them, while directing initial contact through a single access point.

The 111 ‘Press 2’ service provides telephone assessments by local wellbeing practitioners, supervised by registered mental health nurses, offering advice, support and onward referrals where required.

At its November 2025 meeting, the Board agreed to extend the temporary pathway until the end of March 2026. A nine-week engagement exercise followed, running from December 8 to February 9, to gather feedback from patients, professionals and stakeholders on the potential long-term impact.

Andrew Carruthers, Chief Operating Officer at Hywel Dda University Health Board, said: “I would like to thank everyone who took the time to share their views and experiences.

“I would also like to thank West Wales Action for Mental Health for supporting engagement with patients, including those with lived experience, alongside GPs, primary care teams, mental health staff and third sector partners.

“Our priority is to ensure mental health services remain accessible, fair and sustainable. The temporary changes in Ceredigion have shown some positive benefits, and the feedback we have received from across the three counties will play an important role in shaping the Board’s decision.”

The Board will review all evidence and feedback before making a final decision on the future of the adult mental health referral pathway.

GPs will continue to refer patients with urgent or complex needs directly to community mental health teams where appropriate, and have access to a dedicated NHS 111 professional line for additional clinical advice.

Further details, including the full Board papers, are available here:
https://biphdd.gig.cymru/amdanom-ni/eich-bwrdd-iechyd/cyfarfodydd-y-bwrdd-2026/agenda-a-phapuraur-bwrdd-26-mawrth-2026/

The meeting will be streamed live from 9:30am on Thursday (Mar 26) via:
www.youtube.com/hywelddahealthboard1

 

Continue Reading

Health

Parents urged to check children’s vaccinations after meningitis cases

Published

on

Local pharmacy reports MenB vaccine shortage amid rising concern

PARENTS and carers across west Wales are being urged to check their children’s vaccination status following recent meningitis cases in the UK.

The warning comes as a local pharmacy has confirmed a shortage of the Meningitis B (MenB) vaccine, highlighting growing pressure on supplies.

Mendus Pharmacy said it currently has no availability of the vaccine due to what it described as a nationwide supply issue.

Mendus Pharmacy: No availability of the vaccine

In a statement, the pharmacy said: “We would like to inform our patients that, due to ongoing supply issues, we currently have no availability of the Meningitis B vaccine.

“Unfortunately, this is a nationwide shortage and all stock is currently unavailable.

“We understand this may be particularly concerning given the recent outbreak reported in Kent, and we completely appreciate the importance of timely vaccination.”

The pharmacy confirmed it is operating a waiting list and will contact patients once supplies return.

Health officials say keeping vaccinations up to date remains one of the most effective ways to prevent serious illness and reduce pressure on NHS services.

Dr Ardiana Gjini, Executive Director of Public Health at Hywel Dda University Health Board, urged parents to act.

She said: “Vaccination is one of the most effective ways we can protect children and young people from serious illness.

“Ensuring your child is fully vaccinated not only safeguards their health but also helps prevent the spread of infections within our communities.

“I strongly encourage all parents and carers to check their child’s vaccination status. If you are concerned that your child may have missed routine vaccinations, please speak to your GP.”

Meningococcal disease is a serious and potentially life-threatening infection that can lead to meningitis or septicaemia. While many people recover, some are left with long-term physical, neurological or psychological complications. Around one in ten cases can be fatal.

Although the disease can affect anyone, babies, young children, teenagers and young adults are at greatest risk.

In Wales, vaccines protecting against meningococcal strains A, B, C, W and Y are offered as part of the NHS immunisation programme. Infants receive the MenB vaccine, while teenagers are offered the MenACWY vaccine.

Latest figures from the Health Board show that uptake among 16-year-olds for the MenACWY vaccine stands at 76.4%, meaning a significant number of young people remain unprotected as they approach adulthood.

For younger children, uptake of the MenB vaccine is higher but still below the recommended 95% target. Around 92.8% of infants are vaccinated by their first birthday, rising slightly to 91.8% by their second.

Health officials say these figures reflect strong engagement from families and primary care teams but stress that continued vigilance is needed.

Families are being advised to check their child’s vaccination record with their GP or by contacting the Health Board directly. Parents should also ensure babies receive their scheduled MenB doses and that teenagers receive their MenACWY and 3-in-1 booster vaccines, which are currently being delivered in schools.

Parents are also urged to remain alert to the symptoms of meningitis and septicaemia and to seek urgent medical advice if they have concerns.

Further information on symptoms is available via NHS 111 Wales.

 

Continue Reading

Community5 hours ago

Broad Haven volunteers secure ‘national asset’ status for nature reserve

A SMALL stretch of woodland and former opencast coal mine has been transformed into a nationally recognised biodiversity site, in...

Entertainment1 day ago

Tenby steams up in spectacular style as crowds flock to festival

Colourful parade, towering creations and Victorian flair bring town centre to life TENBY was transformed into a vibrant Victorian fantasy...

Crime2 days ago

Publican jailed for six years for supplying cocaine and cannabis

Milford Haven man sentenced at Swansea Crown Court following drug dealing operation A MILFORD HAVEN publican has been jailed for...

Local Government2 days ago

Poverty summit highlights support efforts across Pembrokeshire

A SUMMIT bringing together key organisations from across Pembrokeshire has highlighted both the scale of local poverty and the work...

Education3 days ago

Milford Haven school plans unveiled but funding not yet secured

PLANS for a new £100 million school in Milford Haven have been unveiled, but the project has not yet secured...

News3 days ago

Council unveils plans for new state-of-the-art secondary school in Milford Haven

PEMBROKESHIRE COUNTY COUNCIL has revealed plans for a new state-of-the-art school in Milford Haven, promising modern, inspiring learning spaces for...

Health3 days ago

NHS waiting list falls — but cancer delays and diagnostic backlog worsen

Record progress claimed by Welsh Government as critics warn key targets are still being missed THE NHS in Wales has...

Crime4 days ago

Rapist jailed after ‘abhorrent’ attacks on woman and children

Haverfordwest man told police “women won’t have sex without force” A HAVERFORDWEST man who raped a woman and a young...

News5 days ago

Reform secures first Pembrokeshire councillor in Hakin by-election win

Late Reform candidate takes seat as independent surge and Labour withdrawal shape contest REFORM UK candidate Scott Thorley has won...

News5 days ago

Scott Thorley elected as Pembrokeshire’s first Reform councillor

REFORM UK candidate Scott Thorley has won the Hakin by-election after securing 179 votes. The full result is as follows:...

Popular This Week